PRELP Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-25069
Key Product Details
Species Reactivity
Validated:
Human
Predicted:
Rat (96%). Backed by our 100% Guarantee.
Applications
Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody has been engineered to specifically recognize the recombinant protein PRELP using the following amino acid sequence: GLRWINLDNNRIRKIDQRVLEKLPG
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for PRELP Antibody
Immunocytochemistry/Immunofluorescence: PRELP Antibody [NBP3-25069]
Staining of human cell line U2OS shows localization to endoplasmic reticulum.Applications for PRELP Antibody
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
0.25-2 µg/ml
Application Notes
For ICC/IF, we recommend using a combination of PFA and Triton X-100. This will give you the optimal results for your experiments.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, pH 7.2, 40% glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: PRELP
Long Name
Proline-arginine-Rich End Leucine-rich repeat Protein
Alternate Names
MST161, MSTP161, Prolargin, SLRR2A
Gene Symbol
PRELP
Additional PRELP Products
Product Documents for PRELP Antibody
Product Specific Notices for PRELP Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...